Trend in approval of targeted biologics in the last two decades
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2024.
第一著者: | Siddika, Khadiza |
---|---|
その他の著者: | Ahmed, Syeda Maliha |
フォーマット: | 学位論文 |
言語: | English |
出版事項: |
Brac University
2024
|
主題: | |
オンライン・アクセス: | http://hdl.handle.net/10361/24296 |
類似資料
-
Targeted therapeutic options in the treatment of Breast Cancer
著者:: Alam, Kazi Tasnuva
出版事項: (2022) -
Study on anticancer drugs approved by the FDA from 2014 to 2023
著者:: Rattry, Faria Rahman
出版事項: (2024) -
Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
著者:: Tania, Umme
出版事項: (2023) -
RIPK pathway, as a potential target, for cancer treatment - a review
著者:: Jahan, Nusrat
出版事項: (2024) -
Molecular biology : genes to proteins /
著者:: Tropp, Burton E.
出版事項: (2008)